6 HCV Genotyping 9G test for HCV 1a, 1b, 2, 3, 4 and 6 (6a, 6f, 6i and 6n) with high accuracy

Area of Science:

• Hepatology
• Virology
• Clinical Diagnostics

Background:

• Accurate detection of Hepatitis C Virus (HCV) genotypes is essential for effective treatment according to EASL and WHO guidelines.
• HCV genotyping is critical for guiding therapeutic strategies and managing patient outcomes.

Purpose of the Study:

• To evaluate the performance of the HCV Genotyping 9G test for simultaneous detection of multiple HCV genotypes.
• To assess the accuracy, sensitivity, and specificity of the HCV Genotyping 9G test compared to sequence analysis.

Main Methods:

• The HCV Genotyping 9G test was used to analyze 152 serum samples from HCV-infected patients and healthy individuals.
• Performance was evaluated by comparing results with sequence analysis under blinded conditions.
• Key performance metrics included kappa coefficient, sensitivity, and specificity.

Main Results:

• The HCV Genotyping 9G test demonstrated high agreement with sequence analysis, indicated by high kappa values.
• The test achieved a sensitivity of 99.1% and a specificity of 99.7%.
• Simultaneous genotyping of HCV 1a, 1b, 2, 3, 4, and 6 (including subtypes 6a, 6f, 6i, 6n) was achieved within 30 minutes.

Conclusions:

• The HCV Genotyping 9G test is a rapid, reliable, sensitive, and accurate method for HCV screening and genotyping.
• This test is suitable for clinical specimens, aiding in timely and effective Hepatitis C management.
• The test's performance supports its use in clinical settings for efficient HCV diagnosis.